CMS To Issue Guidance Interpreting Affordable Care Act's Effect On Medicaid Formularies
This article was originally published in The Pink Sheet Daily
Executive Summary
Confusion has arisen as to whether the health reform statute's changes to Medicaid drug rebates means that a state Medicaid program's fee-for-service and managed care organization formularies must be identical.
You may also be interested in...
Medicaid Expansion Demos Give Drug Firms A Break From Rebates
CMS has approved an expansion of Medicaid that would not include rebates for drugs used by the newly eligible population under the Affordable Care Act. The agency is also evaluating a demonstration from Iowa that does not collect drug rebates on individuals eligible under ACA.
Medicaid MCOs Retain Formulary Flexibility Under Affordable Care Act
CMS clarifies that Medicaid drug rebate provisions under the Affordable Care Act should not be interpreted to mean that a state's Medicaid fee-for-service and managed care organizations must have the same formularies.
Medicaid MCOs Retain Formulary Flexibility Under Affordable Care Act
CMS clarifies that Medicaid drug rebate provisions under the Affordable Care Act should not be interpreted to mean that a state's Medicaid fee-for-service and managed care organizations must have the same formularies.